scispace - formally typeset
M

M. Williams

Researcher at University of Cambridge

Publications -  6
Citations -  403

M. Williams is an academic researcher from University of Cambridge. The author has contributed to research in topics: Schizophrenia & Third ventricle. The author has an hindex of 6, co-authored 6 publications receiving 397 citations.

Papers
More filters
Journal ArticleDOI

Psychopathological syndromes in the functional psychoses: associations with course and outcome.

TL;DR: It was found that dimensional representations of psychopathological features were considerably more useful than categorical representations (DSM-III-R and ICD-10) as predictors of illness course and treatment decisions.
Journal ArticleDOI

Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach to analysis.

TL;DR: A case-control study was undertaken of volumetric computerized tomographic scan measures in 216 consecutive admissions for functional psychosis and 67 healthy community controls, finding no large or significant associations between ventricle dimensions and age at onset, duration of illness or pre-morbid social functioning.
Journal ArticleDOI

The ventricular-brain ratio (VBR) in functional psychoses: the relationship of lateral ventricular and total intracranial area

TL;DR: It is argued that analysis of variance, using lateral ventricular area and intra-cranial area, is more informative than VBR in examining these structural changes in functional psychoses.
Journal ArticleDOI

Increased intracerebral cerebrospinal fluid spaces predict unemployment and negative symptoms in psychotic illness : a prospective study

TL;DR: Findings support the notion that dimensions of the cerebral ventricles are a continuous risk factor for some measures of outcome in the functional psychoses.
Journal ArticleDOI

Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: An epidemiological approach to analysis

TL;DR: This finding supports the position of the 5-HT2 receptor as potential mediator of atypical effects of antipsychotic action in patients treated with low to moderate doses of clozapine.